EUVIMEDEUVIMED entdecken
Open Access

A Potential Nontraditional Approach To Combat tmexCD1-toprJ1- Mediated Tigecycline Resistance: Melatonin as a Synergistic Adjuvant of Tigecycline

Xiaoming Wang iD, Ting Liu, Xi Lv, Naiyan Sun, Fan Li, Lei Luo, Xiangkai Zhuge iD, Jinhu Huang iD, Liping Wang iD

Antimicrobial Agents and Chemotherapy · 2023

DOI: 10.1128/aac.00047-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Xiaoming Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjin…. Hauptthemen laut MEDLINE: Melatonin, Klebsiella Infections. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of TMexCD1-TOprJ1, a novel transferable resistance-nodulation-division (RND)-type efflux pump conferring resistance to tigecycline, is now a serious public health issue in the world. Here, we found that melatonin synergistically enhanced the antibacterial efficacy of tigecycline against tmexCD1-toprJ1 -positive Klebsiella pneumoniae by disrupting the proton driving force and efflux function to promote the accumulation of tigecycline into cells, damaging cell membrane integrity and causing the leakage of cell contents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninKlebsiella InfectionsAnimalsMiceTigecyclineMinocyclineDrug Resistance, BacterialMembrane Transport ProteinsAnti-Bacterial AgentsAdjuvants, ImmunologicAdjuvants, PharmaceuticMicrobial Sensitivity TestsKlebsiella pneumoniae

Stichwörter der Autor:innen

melatonin/tigecycline combinationmelatonin/tigecycline hybridsynergistic effecttigecycline resistance

Substanzen

TigecyclineMelatoninMinocyclineMembrane Transport ProteinsAnti-Bacterial AgentsAdjuvants, ImmunologicAdjuvants, Pharmaceutic

Autor:innen und Institutionen

  • MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.
  • Risk Assessment Center of Veterinary Drug Residue and Antimicrobial Resistance, Nanjing Agricultural University, Nanjing, China.
  • College of Pharmaceutical Sciences, Southwest University, Chongqing, China.
  • Department of Nutrition and Food Hygiene, School of Public Health, Nantong University, Nantong, China.

ORCID-Profile: Xiaoming Wang, Xiangkai Zhuge, Jinhu Huang, Liping Wang

Förderung

  • The National Key Research and Development Program of China

Zitieren

APA

Wang, X., Liu, T., Lv, X., Sun, N., Li, F., Luo, L., Zhuge, X., Huang, J., & Wang, L. (2023). A Potential Nontraditional Approach To Combat tmexCD1-toprJ1- Mediated Tigecycline Resistance: Melatonin as a Synergistic Adjuvant of Tigecycline. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00047-23

Vancouver

Wang X, Liu T, Lv X, Sun N, Li F, Luo L, et al. A Potential Nontraditional Approach To Combat tmexCD1-toprJ1- Mediated Tigecycline Resistance: Melatonin as a Synergistic Adjuvant of Tigecycline. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.00047-23

BibTeX
@article{Wang2023,
  author = {Wang, Xiaoming and Liu, Ting and Lv, Xi and Sun, Naiyan and Li, Fan and Luo, Lei and Zhuge, Xiangkai and Huang, Jinhu and Wang, Liping},
  title = {A Potential Nontraditional Approach To Combat tmexCD1-toprJ1- Mediated Tigecycline Resistance: Melatonin as a Synergistic Adjuvant of Tigecycline},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  doi = {10.1128/aac.00047-23}
}
Kostenlos starten →